194 related articles for article (PubMed ID: 28734870)
1. Elucidation of the neural circuits activated by a GABA
Pizzo R; O'Leary OF; Cryan JF
Neuropharmacology; 2018 Jul; 136(Pt A):129-145. PubMed ID: 28734870
[TBL] [Abstract][Full Text] [Related]
2. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
[TBL] [Abstract][Full Text] [Related]
3. GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine.
Lhuillier L; Mombereau C; Cryan JF; Kaupmann K
Neuropsychopharmacology; 2007 Feb; 32(2):388-98. PubMed ID: 16710312
[TBL] [Abstract][Full Text] [Related]
4. Involvement of GABAB receptors in biochemical alterations induced by anxiety-related responses to nicotine in mice: genetic and pharmacological approaches.
Varani AP; Pedrón VT; Bettler B; Balerio GN
Neuropharmacology; 2014 Jun; 81():31-41. PubMed ID: 24486711
[TBL] [Abstract][Full Text] [Related]
5. The GABA
Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
[TBL] [Abstract][Full Text] [Related]
6. The GABA
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2017 Jan; 794():135-146. PubMed ID: 27876620
[TBL] [Abstract][Full Text] [Related]
7. GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation.
Mombereau C; Lhuillier L; Kaupmann K; Cryan JF
J Pharmacol Exp Ther; 2007 Apr; 321(1):172-7. PubMed ID: 17215447
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
[TBL] [Abstract][Full Text] [Related]
9. Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization.
Gjoni T; Urwyler S
Neuropharmacology; 2008 Dec; 55(8):1293-9. PubMed ID: 18775443
[TBL] [Abstract][Full Text] [Related]
10. Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge.
Nguyen NK; Keck ME; Hetzenauer A; Thoeringer CK; Wurst W; Deussing JM; Holsboer F; Müller MB; Singewald N
Psychopharmacology (Berl); 2006 Oct; 188(3):374-85. PubMed ID: 16953386
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous activation of muscarinic and GABA
Cieślik P; Woźniak M; Tokarski K; Kusek M; Pilc A; Płoska A; Radulska A; Pelikant-Małecka I; Żołnowska B; Sławiński J; Kalinowski L; Wierońska JM
Behav Brain Res; 2019 Feb; 359():671-685. PubMed ID: 30267715
[TBL] [Abstract][Full Text] [Related]
12. Point mutations in the transmembrane region of GABAB2 facilitate activation by the positive modulator N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) in the absence of the GABAB1 subunit.
Dupuis DS; Relkovic D; Lhuillier L; Mosbacher J; Kaupmann K
Mol Pharmacol; 2006 Dec; 70(6):2027-36. PubMed ID: 16966477
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits.
Rajalu M; Fritzius T; Adelfinger L; Jacquier V; Besseyrias V; Gassmann M; Bettler B
Neuropharmacology; 2015 Jan; 88():145-54. PubMed ID: 25196734
[TBL] [Abstract][Full Text] [Related]
14. Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382.
van Nieuwenhuijzen PS; McGregor IS; Chebib M; Hunt GE
Neuroscience; 2014 Sep; 277():700-15. PubMed ID: 25088910
[TBL] [Abstract][Full Text] [Related]
15. Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats.
Shoji H; Mizoguchi K
J Ethnopharmacol; 2013 Aug; 149(1):93-102. PubMed ID: 23770052
[TBL] [Abstract][Full Text] [Related]
16. Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: evidence for widespread endogenous tone at brain mGlu2/3 receptors in vivo.
Linden AM; Bergeron M; Schoepp DD
Neuropharmacology; 2005; 49 Suppl 1():120-34. PubMed ID: 16023151
[TBL] [Abstract][Full Text] [Related]
17. Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat.
Sherwin E; Lennon A; Harkin A
Int J Neuropsychopharmacol; 2017 Oct; 20(10):833-843. PubMed ID: 28977524
[TBL] [Abstract][Full Text] [Related]
18. Regional specific modulation of neuronal activation associated with nitric oxide synthase inhibitors in an animal model of antidepressant activity.
Sherwin E; Gigliucci V; Harkin A
Behav Brain Res; 2017 Jan; 316():18-28. PubMed ID: 27569181
[TBL] [Abstract][Full Text] [Related]
19. Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats.
Orrù A; Lai P; Lobina C; Maccioni P; Piras P; Scanu L; Froestl W; Gessa GL; Carai MA; Colombo G
Eur J Pharmacol; 2005 Nov; 525(1-3):105-11. PubMed ID: 16289452
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.
Maccioni P; Zaru A; Loi B; Lobina C; Carai MA; Gessa GL; Capra A; Mugnaini C; Pasquini S; Corelli F; Hyytiä P; Lumeng L; Colombo G
Alcohol Clin Exp Res; 2012 Oct; 36(10):1748-66. PubMed ID: 22486245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
